NCT05363111 2025-10-29Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple MyelomaCity of Hope Medical CenterPhase 1 Recruiting15 enrolled